FDA, DHS increase coordination for medical device cybersecurity

Editor's Note

The Food and Drug Administration (FDA) on October 16 announced that as part of the Administration’s efforts to strengthen cybersecurity in healthcare, the FDA and Department of Homeland Security (DHS) have agreed to greater coordination and cooperation for addressing cybersecurity in medical devices.

Under the agreement, DHS will continue to serve as the central medical device vulnerability coordination center and interface with appropriate stakeholders, including consulting with the FDA for technical and clinical expertise.

The FDA will continue to engage in−regular, ad hoc, and emergency coordination−calls with DHS and advise DHS on the risk to patient health and potential for harm posed by cybersecurity threats and vulnerabilities.